Robins Kaplan Adds Wilson Sonsini Drug Patent Atty In NY

Law360, New York (July 05, 2012, 2:48 PM ET) -- Robins Kaplan Miller & Ciresi LLP has boosted its life sciences and Hatch-Waxman intellectual property group in New York with the addition of a former Wilson Sonsini Goodrich & Rosati PC attorney who specializes in generic pharmaceutical patent cases.

Jeffrey Hovden, who is joining the firm as a partner, focuses on such cases under the Hatch-Waxman Act and within the biotechnology industry with clients including generics makers and name-brand drugmakers. The firm announced the addition of Hovden on June 25.

Ronald J. Schutz, the chairman of...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers